300485 Stock Overview A biopharmaceutical company, engages in the research and development, production, and sales of injections in China. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Beijing Science Sun Pharmaceutical Co., Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for Beijing Science Sun Pharmaceutical Historical stock prices Current Share Price CN¥6.82 52 Week High CN¥10.30 52 Week Low CN¥5.73 Beta 0.025 1 Month Change -17.73% 3 Month Change -13.89% 1 Year Change -32.48% 3 Year Change -50.40% 5 Year Change -22.76% Change since IPO -70.82%
Recent News & Updates
Beijing Science Sun Pharmaceutical Co., Ltd. to Report Fiscal Year 2024 Results on Mar 29, 2025 Dec 31
Third quarter 2024 earnings released: EPS: CN¥0.013 (vs CN¥0.12 loss in 3Q 2023) Oct 25
Beijing Science Sun Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Sep 30
Second quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.52 in 2Q 2023) Aug 28
Beijing Science Sun Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Jun 29
Dividend reduced to CN¥0.022 May 25 See more updates
Beijing Science Sun Pharmaceutical Co., Ltd. to Report Fiscal Year 2024 Results on Mar 29, 2025 Dec 31
Third quarter 2024 earnings released: EPS: CN¥0.013 (vs CN¥0.12 loss in 3Q 2023) Oct 25
Beijing Science Sun Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Sep 30
Second quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.52 in 2Q 2023) Aug 28
Beijing Science Sun Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Jun 29
Dividend reduced to CN¥0.022 May 25
Beijing Science Sun Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024 May 25
First quarter 2024 earnings released: CN¥0.40 loss per share (vs CN¥0.002 profit in 1Q 2023) Apr 26
Beijing Science Sun Pharmaceutical Co., Ltd., Annual General Meeting, Apr 30, 2024 Apr 10
Full year 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.43 in FY 2022) Apr 10
Beijing Science Sun Pharmaceutical Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Mar 30
Investor sentiment deteriorates as stock falls 17% Feb 02
Insufficient new directors Feb 01
Beijing Science Sun Pharmaceutical Co., Ltd. Announces Executive Changes Jan 30
Beijing Science Sun Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 10, 2024 Dec 30
Third quarter 2023 earnings released: CN¥0.12 loss per share (vs CN¥0.037 profit in 3Q 2022) Oct 27
Second quarter 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.27 in 2Q 2022) Aug 25
Beijing Science Sun Pharmaceutical Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date of 23 May 2023 May 17
First quarter 2023 earnings released: EPS: CN¥0.002 (vs CN¥0.22 in 1Q 2022) Apr 26
Investor sentiment improved over the past week Dec 12
Third quarter 2022 earnings released: EPS: CN¥0.037 (vs CN¥0.11 in 3Q 2021) Oct 27
Second quarter 2022 earnings released: EPS: CN¥0.27 (vs CN¥0.09 in 2Q 2021) Aug 27
Beijing Science Sun Pharmaceutical Co., Ltd. Announces Cash Dividend for the Fiscal Year 2021, Payable on 31 May 2022 May 27
First quarter 2022 earnings released: EPS: CN¥0.22 (vs CN¥0.09 in 1Q 2021) Apr 30
Beijing Science Sun Pharmaceutical Co., Ltd. Approves the Profit Distribution of Final Cash Dividend for the Year 2021 Apr 24
Beijing Science Sun Pharmaceutical Co., Ltd., Annual General Meeting, Apr 21, 2022 Apr 02
Full year 2021 earnings released: EPS: CN¥0.84 (vs CN¥0.32 in FY 2020) Apr 02
Beijing Science Sun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021 Apr 01
Investor sentiment improved over the past week Mar 16
Investor sentiment improved over the past week Jan 19
Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.09 in 3Q 2020) Oct 28
Second quarter 2021 earnings released: EPS CN¥0.09 (vs CN¥0.14 in 2Q 2020) Aug 28
Investor sentiment improved over the past week Aug 04
Upcoming dividend of CN¥0.065 per share May 03
First quarter 2021 earnings released: EPS CN¥0.09 (vs CN¥0.05 in 1Q 2020) Apr 29
Full year 2020 earnings released: EPS CN¥0.32 (vs CN¥0.31 in FY 2019) Mar 30
New 90-day low: CN¥11.30 Mar 13
Full year 2020 earnings released: EPS CN¥0.31 (vs CN¥0.31 in FY 2019) Mar 06
Beijing Science Sun Pharmaceutical Co., Ltd. to Report Fiscal Year 2020 Results on Mar 30, 2021 Feb 24
Beijing Science Sun Pharmaceutical Co., Ltd. Announces Directorate Changes Jan 31
New 90-day low: CN¥12.45 Jan 28
New 90-day low: CN¥13.92 Jan 07
New 90-day low: CN¥16.02 Dec 12
Third quarter earnings released Oct 28
Beijing Science Sun Pharmaceutical Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020 Oct 20
New 90-day low - CN¥16.09 Sep 10
First half earnings released Aug 29
Beijing Science Sun Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020 Aug 13 Shareholder Returns 300485 CN Biotechs CN Market 7D -2.7% -3.7% -4.1% 1Y -32.5% -22.3% 6.9%
See full shareholder returns
Return vs Industry: 300485 underperformed the CN Biotechs industry which returned -23.2% over the past year.
Return vs Market: 300485 underperformed the CN Market which returned 6.4% over the past year.
Price Volatility Is 300485's price volatile compared to industry and market? 300485 volatility 300485 Average Weekly Movement 5.8% Biotechs Industry Average Movement 6.8% Market Average Movement 7.7% 10% most volatile stocks in CN Market 11.6% 10% least volatile stocks in CN Market 4.9%
Stable Share Price: 300485 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300485's weekly volatility (6%) has been stable over the past year.
About the Company Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sales of injections in China. It offers products for cardiovascular, cerebrovascular, immunomodulation, nervous systems, and other varieties. The company is also engaged in the research, development, production, and sale of raw materials; extraction of traditional Chinese medicine; and the manufacture of Chinese and Western medicine preparations.
Show more Beijing Science Sun Pharmaceutical Co., Ltd. Fundamentals Summary How do Beijing Science Sun Pharmaceutical's earnings and revenue compare to its market cap? 300485 fundamental statistics Market cap CN¥3.28b Earnings (TTM ) -CN¥191.81m Revenue (TTM ) CN¥405.63m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 300485 income statement (TTM ) Revenue CN¥405.63m Cost of Revenue CN¥138.45m Gross Profit CN¥267.17m Other Expenses CN¥458.98m Earnings -CN¥191.81m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 29, 2025
Earnings per share (EPS) -0.40 Gross Margin 65.87% Net Profit Margin -47.29% Debt/Equity Ratio 0%
How did 300485 perform over the long term?
See historical performance and comparison Dividends
0.3% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/08 04:10 End of Day Share Price 2025/01/08 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Beijing Science Sun Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Pei Hui Tang Chasing Securities
Show 0 more analysts 
